Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults
- 1 January 2009
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines
- Vol. 5 (1) , 33-40
- https://doi.org/10.4161/hv.5.1.6348
Abstract
Sixteen dose formulations of our live-attenuated tetravalent dengue virus vaccines (TDV) were previously evaluated for safety and immunogenicity. Two of the sixteen candidate TDV formulations (Form...Keywords
This publication has 0 references indexed in Scilit: